These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15334189)

  • 1. The role of the central histaminergic system on schizophrenia.
    Ito C
    Drug News Perspect; 2004; 17(6):383-7. PubMed ID: 15334189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine and schizophrenia.
    Arrang JM
    Int Rev Neurobiol; 2007; 78():247-87. PubMed ID: 17349864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine H3-receptor inverse agonists as novel antipsychotics.
    Ito C
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of histamine H(3) receptor antagonists on brain histamine metabolism: do all histamine H(3) receptor antagonists act at a single site?
    Barnes W; Boyd D; Hough L
    Eur J Pharmacol; 2001 Nov; 431(2):215-21. PubMed ID: 11728428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
    Zhang M; Ballard ME; Pan L; Roberts S; Faghih R; Cowart M; Esbenshade TA; Fox GB; Decker MW; Hancock AA; Rueter LE
    Brain Res; 2005 May; 1045(1-2):142-9. PubMed ID: 15910772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
    Akhtar M; Uma Devi P; Ali A; Pillai KK; Vohora D
    Fundam Clin Pharmacol; 2006 Aug; 20(4):373-8. PubMed ID: 16867021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
    Morisset S; Sahm UG; Traiffort E; Tardivel-Lacombe J; Arrang JM; Schwartz JC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):590-6. PubMed ID: 9918563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
    Ellenbroek BA; Ghiabi B
    Curr Pharm Des; 2015; 21(26):3760-70. PubMed ID: 26044979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H3 receptor antagonists display antischizophrenic activities in rats treated with MK-801.
    Mahmood D; Akhtar M; Jahan K; Goswami D
    J Basic Clin Physiol Pharmacol; 2016 Sep; 27(5):463-71. PubMed ID: 27089413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
    Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
    J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats.
    Munzar P; Nosál R; Goldberg SR
    Eur J Pharmacol; 1998 Dec; 363(2-3):93-101. PubMed ID: 9881573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of histamine H3-receptor ligands on brain monoamine oxidase in various mammalian species.
    Sakurai E; Sakurai E; Tanaka Y; Watanabe T; Singh Jossan S; Oreland L
    Brain Res; 2001 Jul; 906(1-2):180-3. PubMed ID: 11430877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The histaminergic system: a target for innovative treatments of cognitive deficits].
    Motawaj M; Burban A; Davenas E; Gbahou F; Faucard R; Morisset S; Arrang JM
    Therapie; 2010; 65(5):415-22. PubMed ID: 21144476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.
    von Coburg Y; Kottke T; Weizel L; Ligneau X; Stark H
    Bioorg Med Chem Lett; 2009 Jan; 19(2):538-42. PubMed ID: 19091563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
    Poyurovsky M; Pashinian A; Levi A; Weizman R; Weizman A
    Int Clin Psychopharmacol; 2005 Mar; 20(2):101-3. PubMed ID: 15729086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of brain histamine in acute and chronic stresses.
    Ito C
    Biomed Pharmacother; 2000 Jun; 54(5):263-7. PubMed ID: 10917464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H3 receptor antagonists/inverse agonists as anti-obesity agents.
    Hancock AA
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histaminergic Pharmacology Modulates the Analgesic and Antiedematogenic Effects of Spinally Injected Morphine.
    Stein T; Souza-Silva E; Mascarin L; Eto C; Fin FE; Tonussi CR
    Anesth Analg; 2016 Jul; 123(1):238-43. PubMed ID: 27314696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.
    Jansen FP; Mochizuki T; Maeyama K; Leurs R; Timmerman H
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):60-7. PubMed ID: 10935534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.